Pharmaceutical ProductCached Profile
LIFEVEST
Active Ingredients (Generic):Unmapped
Therapeutic Area: Electromedical and Electrotherapeutic Apparatus
LIFETIME PROMOTIONAL SPEND
$84,766
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
FDA Patient Safety Profile
Dynamic safety indicators compiled from official FDA product labels.
Active Clinical Trials
Clinical studies listing this drug as an active intervention.
LifeVest Trends Validation Protocol
COMPLETEDPhase N/ANCT02149290
Post-market Release Registry of Wearable Defibrillator Use in Patients With Ventricular Dysfunction Following CABG Surgery
TERMINATEDPhase N/ANCT01448005
Study of the Wearable Defibrillator In Heart-Failure Patients
COMPLETEDPhase N/ANCT01326624
Heart Sounds Registry In Patients Using The Wearable Cardioverter Defibrillator (HEARIT-Registry) Study Protocol
COMPLETEDPhase N/ANCT03203629
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
RECRUITINGPhase NANCT04504188
Top Funded Physicians (Cumulative)
Doctors receiving the highest aggregate promotional support for this product.
Dr. TONY MASRIMedical Doctor$10,000
Dr. MEREDITH SCHRAMSKIPhysician Assistant$1,564
Dr. DWAN VARNERMedical Doctor$1,516
Dr. AMANDA KEYSNurse Practitioner$1,500
Dr. TAMAM MOHAMADMedical Doctor$1,500
Drug Marketing Payments Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for LIFEVEST...